These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27488887)

  • 1. Testosterone therapy in men with testosterone deficiency: are the benefits and cardiovascular risks real or imagined?
    Traish AM
    Am J Physiol Regul Integr Comp Physiol; 2016 Sep; 311(3):R566-73. PubMed ID: 27488887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone deficiency and cardiovascular mortality.
    Morgentaler A
    Asian J Androl; 2015; 17(1):26-31. PubMed ID: 25432501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
    Hackett G
    Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency.
    Traish AM
    Sex Med Rev; 2018 Jan; 6(1):86-105. PubMed ID: 29128268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease.
    Traish AM; Zitzmann M
    Rev Endocr Metab Disord; 2015 Sep; 16(3):249-68. PubMed ID: 26590935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study.
    Haider A; Yassin A; Haider KS; Doros G; Saad F; Rosano GM
    Vasc Health Risk Manag; 2016; 12():251-61. PubMed ID: 27366080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk.
    Khera M; Miner M; Jaffe J; Pastuszak AW
    J Sex Med; 2021 Jan; 18(1):83-98. PubMed ID: 33317996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine.
    Morgentaler A; Traish A; Hackett G; Jones TH; Ramasamy R
    Sex Med Rev; 2019 Oct; 7(4):636-649. PubMed ID: 31351915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone deficiency.
    Traish AM; Miner MM; Morgentaler A; Zitzmann M
    Am J Med; 2011 Jul; 124(7):578-87. PubMed ID: 21683825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism).
    Saad F
    Adv Exp Med Biol; 2017; 1043():527-558. PubMed ID: 29224109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major cardiovascular disease risk in men with testosterone deficiency (hypogonadism): appraisal of short, medium and long-term testosterone therapy - a narrative review.
    Traish AM
    Sex Med Rev; 2023 Sep; 11(4):384-394. PubMed ID: 37587664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).
    Khera M; Adaikan G; Buvat J; Carrier S; El-Meliegy A; Hatzimouratidis K; McCullough A; Morgentaler A; Torres LO; Salonia A
    J Sex Med; 2016 Dec; 13(12):1787-1804. PubMed ID: 27914560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone therapy and cardiovascular risk: advances and controversies.
    Morgentaler A; Miner MM; Caliber M; Guay AT; Khera M; Traish AM
    Mayo Clin Proc; 2015 Feb; 90(2):224-51. PubMed ID: 25636998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone treatment in the aging male: myth or reality?
    Nigro N; Christ-Crain M
    Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies in testosterone replacement therapy: testosterone and cardiovascular disease.
    Hwang K; Miner M
    Asian J Androl; 2015; 17(2):187-91. PubMed ID: 25652628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
    Traish A
    Investig Clin Urol; 2016 Nov; 57(6):384-400. PubMed ID: 27847912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogonadism: Therapeutic Risks, Benefits, and Outcomes.
    Sigalos JT; Pastuszak AW; Khera M
    Med Clin North Am; 2018 Mar; 102(2):361-372. PubMed ID: 29406064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency.
    Miner MM; Khera M; Bhattacharya RK; Blick G; Kushner H
    Postgrad Med; 2011 May; 123(3):17-27. PubMed ID: 21566412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?
    Saad F
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():52-9. PubMed ID: 23280867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.